Supplementary Figure 4 from Molecular Characterization of Acquired Resistance to KRAS<sup>G12C</sup>–EGFR Inhibition in Colorectal Cancer
<p>Generation of acquired resistance PDX model</p>
Publications
9 shownSupplementary Figure 1 from Molecular Characterization of Acquired Resistance to KRAS<sup>G12C</sup>–EGFR Inhibition in Colorectal Cancer
<p>Characterization of acquired resistance in vitro models</p>
Supplementary Table 2 from Molecular Characterization of Acquired Resistance to KRAS<sup>G12C</sup>–EGFR Inhibition in Colorectal Cancer
<p>Patients Progression Cell Free DNA data</p>
Supplementary Table 1 from Molecular Characterization of Acquired Resistance to KRAS<sup>G12C</sup>–EGFR Inhibition in Colorectal Cancer
<p>Patients Characteristics</p>
Supplementary Figure 3 from Molecular Characterization of Acquired Resistance to KRAS<sup>G12C</sup>–EGFR Inhibition in Colorectal Cancer
<p>RW7213 cell lines sequencing analysis</p>
Supplementary Figure 5 from Molecular Characterization of Acquired Resistance to KRAS<sup>G12C</sup>–EGFR Inhibition in Colorectal Cancer
<p>Oncoprint of baseline alterations in CRC patients who developed resistance to KRAS G12C and EGFR inhibitors</p>
Supplementary Figure 2 from Molecular Characterization of Acquired Resistance to KRAS<sup>G12C</sup>–EGFR Inhibition in Colorectal Cancer
<p>C106 cell lines single cell sequencing analysis</p>
Supplementary Figure 6 from Molecular Characterization of Acquired Resistance to KRAS<sup>G12C</sup>–EGFR Inhibition in Colorectal Cancer
<p>C106 resistant cells drug withdrawal and Patient #12 MSK-Impact data</p>
Supplementary Table 3 from Molecular Characterization of Acquired Resistance to KRAS<sup>G12C</sup>–EGFR Inhibition in Colorectal Cancer
<p>Patients Longitudinal Cell Free DNA data</p>
Frequent Co-Authors
Researcher Info
- h-index
- 0
- Publications
- 9
- Citations
- 0
External Links
Identifiers
- ORCID
- 0000-0002-9902-5712
Impact Metrics
h-index
0
h-index: Number of publications with at least h citations each.